Abstract Body

Background

Hepatitis C remains a major cause of cirrhosis, liver cancer, and hepatitis-related deaths. Chronic infection affects thousands of Los Angeles County residents annually, underscoring the urgent need for treatment. To evaluate Project Connect, we analyzed linkage-to-cure outcomes.

Methods

Volunteer case-workers contacted Hepatitis C-infected cases reported by a local county health department with three phone call and text attempts. Case-workers assessed patients’ awareness of their infection and treatment status, provided Hepatitis C education, and used a questionnaire to identify appropriate treatment pathways based on the patient’s housing status, insurance, and transportation needs. Patients were referred to treatment programs, including Bienestar, AIDS Health Foundation, telehealth, or their primary care provider. Data was recorded in REDCap and analyzed with SAS Software Version 9.4.

Results

Among 8,408 Hepatitis C-infected cases, reported between January 2023 to September 2025, 2,023 (24%) were successfully contacted. Of these contacts, 1,346 (67%) identified as untreated for Hepatitis C and were offered the opportunity to participate in the program. Among them, 779 (58%) participated, 371 (28%) refused, and 196 (14%) were not eligible for the program. Refusal was due to lack of interest in treatment, needing time to consider results, planning to contact their PCP, or other health priorities. Ineligibility was due to residing outside of Los Angeles County, a negative RNA result, already having an appointment, ongoing contact with a primary care physician for Hepatitis C, or insurance issues. Among those receiving help for linkage, 401 (51%) were linked to a provider for treatment evaluation (testing, initiating, or completed treatment), 188 (24%) were in process for linkage, and 190 (25%) were not linked to care by the 2-month follow-up.

Conclusions

Project Connect demonstrates the feasibility of linking patients to hepatitis C treatment. Our findings show that outreach and referral alone are insufficient, highlighting the need for stronger patient navigation and expanded access to care to increase treatment initiation.